v3.26.1
Debt Obligations - Life Sciences Narrative (Details) - USD ($)
 3 Months Ended 6 Months Ended
Aug. 04, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Aug. 04, 2024
Jan. 31, 2024
Debt Instrument [Line Items]                
Accrued interest and exit fees   $ 19,300,000   $ 19,300,000   $ 18,400,000    
Current portion of debt obligations   $ 553,900,000   $ 553,900,000   518,600,000    
R2 Technologies | Lancer Promissory Note | Related Party | Life Sciences                
Debt Instrument [Line Items]                
Optional prepayment, number of days written notice 5 days              
Interest rate 12.00% 12.00%   12.00%        
Face amount $ 43,500,000              
Short-term debt   $ 50,900,000   $ 50,900,000   $ 47,900,000    
Interest rate, effective percentage   17.00%   17.00%   17.00%    
Interest expense, debt   $ 2,100,000 $ 5,200,000 $ 4,100,000 $ 9,700,000      
Interest costs capitalized       3,000,000.0 $ 2,500,000      
Current portion of debt obligations   50,700,000   50,700,000   $ 46,600,000    
Outstanding debt   50,900,000   50,900,000   47,900,000    
Unamortized discount   $ 200,000   $ 200,000   $ 1,300,000    
R2 Technologies | Senior Notes, Due 2025, 20.00% | Related Party | Life Sciences                
Debt Instrument [Line Items]                
Face amount $ 20,000,000.0              
Short-term debt               $ 17,400,000
Accrued interest and exit fees             $ 7,000,000.0 $ 2,600,000
Exit fees (non-current portion)             $ 16,500,000  
Extension fee percentage 5.00%              
Debt instrument, extension fee $ 2,200,000